Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: A 9-year study in the UK for treating recurrent urinary tract infections in men and women

Saved in:
Bibliographic Details
Published in:European urology 2024-03, Vol.85, p.S1037
Main Authors: Kanabar, S., Foley, S., Yang, B.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(24)00833-9